Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses

AIDS Research and Human Retroviruses

Volumn 13, Issue 11, 1997, Pages 945-952

  Staats, Herman F ^a   Montgomery, Sean P ^a   Palker, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INTRAGASTRIC DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION;

EID: 0030785587     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.945     Document Type: Article

References (41)

1. Mestecky J and Jackson S: Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J Clin Immunol 1994; 14:259-272.
2. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Cruz VP, Chui D-S, Osathanondh R, Mayer K, and Essex M: HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-1293.
3. Blauvelt A and Katz SI: The skin as target, vector, and effector organ in human immunodeficiency virus disease. J Invest Dermatol 1995;105:S122-S126.
4. Ayehunie S, Groves RW, Bruzzese AM, Ruprecht RM, Kupper TS, and Langhoff E: Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact. AIDS Res Hum Retroviruses 1995;11:877-884.
5. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, and Ho DD: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996; 183:215-225.
6. Kilian M and Russell MW: Function of mucosal immunoglobulins. In: Handbook of Mucosal Immunology. Academic Press, San Diego, California, 1994, p. 127.
7. London SD: Cytotoxic Lymphocytes in mucosal effector sites. In: Handbook of Mucosal Immunology. Academic Press, San Diego, California, 1994, p. 325.
8. Kiyono H and McGhee JR: T helper cells for mucosal immune responses. In: Handbook of Mucosal Immunology. Academic Press, San Diego, California, 1994, p. 263.
9. Mazanec MB, Nedrud JG, Kaetzel CS, and Lamm ME: A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993;14:430-435.
10. Winner L, Mack J, Weltzin R, Mekalanos JJ, Kraehenbuhl J-P, and Neutra MR: New model for analysis of mucosal immunity: Intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun 1991;59:977-982.
11. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, and Neutra MR: Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 1992;60:1786-1792.
12. Burns JW, Siadat-Pajouh M, Krishnaney AA, and Greenberg HB: Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272: 104-107.
13. Lehner T, Panagiotidi C, Bergmeier LA, Ping T, Brookes R, and Adams SE: A comparison of the immune responses following oral, vaginal or rectal route of immunization with SIV antigens in non-human primates. Vaccine Res 1992;1:319-330.
14. Lehner T, Tao L, Panagiotidi C, Klavinskis LS, Brookes R, Hussain L, Meyeres N, Adams SE, Gearing AJ, and Bergmeier LA: Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol 1994;68:1624-1632.
15. Staats HF, Nichols WG, and Palker TJ: Mucosal immunity to HIV-1: Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10MN(A). J Immunol 1996;157:462-472.
16. Cease KB, Margalit H, Cornette JL, Putney SD, Robey WG, Onyang C, Streider HZ, Fischinger PJ, Gallo RC, LeLisi C, and Berzofsky JA: Helper T cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein an induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci USA 1987;84:4249-4253.
17. Hart MK, Weinhold KJ, Scearce RM, Washburn EM, Clark CA, Palker TJ, and Haynes BF: Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides. Proc Natl Acad Sci USA 1991;88:9448-9452.
18. Takahashi H, Cohen J, Hosmalin A, Cease KB, Houghten R, Cornetter JL, DeLisi C, Moss B, Germain RN, and Berzofsksy JA: An Immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1988;85:3105-3109.
19. Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, and McGhee JR: Mucosal adjuvant effect of cholera toxin in mice results from T helper 2 (Th2) cells and IL-4. J Immunol 1995; 155:4621-4629.
20. Snider DP, Marshall JS, Perdue MH, and Liang H: Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J Immunol 1994;153:647-657.
21. Palker TJ, Matthews TJ, Langlois A, Tanner ME, Martin ME, Scearce RM, Kim JA, Berzofsky JA, Bolognesi DP, and Haynes BH: Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol 1989;142:3612-3619.
22. Hart MK, Palker TJ, Matthews TJ, Langlois AJ, lerche NW, Martin ME, Scearce RM, McDanal C, Bolognesi DP, and Haynes BF: Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys. J Immunol 1990;145:2677-2685.
23. Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C, et al.: Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides. J Immunol 1993;151:1646-1653.
24. Xu-Amano J, Kiyono H, Jackson RJ, Staats HF, Fujihashi K, Burrows PD, Elson CO, Pillai S, and McGhee JR: Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993;178:1309-1320.
25. Haneberg B, Kendall D, Amerongen HM, Apter FM, Kraehenbuhl JP, and Neutra MR: Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun 1994;62:15-23.
26. Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, and McGhee JR: Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol 1994;6:572-583.
27. Menge AC, Michalek SM, Russell MW, and Mestecky J: Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect Immun 1993;61:2162-2171.
28. O'Hagan DT, Rafferty D, McKeating JA, and Ilium L: Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein. J Gen Virol 1992; 73:2141-2145.
29. Thaper MA, Parr EL, and Parr MB: Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 1990;70:121-125.
30. Thapar MA, Parr EL, Bozzola JJ, and Parr MB: Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). Vaccine 1991;9:129-133.
31. Hashigucci K, Ogawa H, Ishidate T, Yamashita R, Kamiya H, Watanabe K, Hattori N, Sato T, Suzuki Y, Nagamine T, Aizawa C, Tamura S, Kurata T, and Oya A: Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 1996;14:113-119.
32. Russell MW, Moldoveanu Z, White PL, Sibert GJ, Mestecky J, and Michalek SM: Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect Immun 1996; 64:1272-1283.
33. Parr EL and Parr MB: Immunization for a secretory immune response in the female reproductive tract. Vaccine Res 1992;1:221-225.
34. Di Tommaso A, Saletti G, Pizza M, Rappuoli R, Dougan G, Abrignani S, Douce G, and De Magistris MT: Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun 1996;64:974-979.
35. McLean CS, Challanain DN, Duncan I, Boursnell MEG, Jennings R, and Inglis SC: Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine. Vaccine 1996; 14:987-992.
36. Lehner T, Brookes R, Panagiotidi C, Tao L, Klavinskis LS, Walker J, Walker P, Ward R, Hussain L, Gearing JH, Adams SE, and Bergmeier LA: T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci USA 1993; 90:8638-8642.
37. Partidos CD, Vohra P, Stanley CM, Howard CR, and Steward MW: Induction of systemic immune responses to orally administered synthetic peptides. Vaccine Res 1995;4:113-120.
38. Kutteh WH and Mestecky J: Secretory immunity in the female reproductive tract. Am J Reprod Immunol 1994;31:40-46.
39. Auci DL, Chice SM, Heusser C, Athanassiades TJ, and Durkin HG: Origin and fate of IgE-bearing lymphocytes. II. Gut-associated lymphoid tissue as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicilloyl-keyhold limpet hemocyanin by various routes: Relation to asialo GM1 ganglioside+ cells and IgE/ CD23 immune complexes. J Immunol 1992;149:2241-2248.
40. Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Corse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, McCutchan FE, Burke DS, and the National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group: Immunization with envelope subunit vaccine products elicits neutralization antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. J Infect Dis 1996; 173:340-348.
41. Burns JW, Siadat-Pajouh M, Krishnaney AA, and Breenberg HB: Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272:104-107.